172 related articles for article (PubMed ID: 3514472)
1. [Respiratory tract infections--clinical results with ofloxacin].
Shah PM; Knothe H
Infection; 1986; 14 Suppl 1():S79-81. PubMed ID: 3514472
[TBL] [Abstract][Full Text] [Related]
2. Overview of experience with ofloxacin in respiratory tract infection.
Ball P
Scand J Infect Dis Suppl; 1990; 68():56-63. PubMed ID: 2218424
[TBL] [Abstract][Full Text] [Related]
3. [New oral quinolone compounds in chronic bronchitis].
Davies BI; Maesen FP; Teengs JP; Baur C
Infection; 1986; 14 Suppl 1():S73-8. PubMed ID: 2937739
[TBL] [Abstract][Full Text] [Related]
4. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
Pfaller MA; Ehrhardt AF; Jones RN
Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
[TBL] [Abstract][Full Text] [Related]
5. An open randomised comparison of ofloxacin and doxycycline in lower respiratory tract infections.
Harazim H; Wimmer J; Mittermayer HP
Drugs; 1987; 34 Suppl 1():71-3. PubMed ID: 3481331
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
9. Comparative activity of ofloxacin with reference to bacterial strains isolated in in-patients and out-patients.
Rubinstein E; Mark Z; Keren G; Alkan M; Berger S; Bogokowski B
Infection; 1986; 14 Suppl 1():S20-5. PubMed ID: 3514469
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
[TBL] [Abstract][Full Text] [Related]
11. Oral ofloxacin therapy for lower respiratory tract infection.
Gentry LO; Lipsky B; Farber MO; Tucker B; Rodriguez-Gomez G
South Med J; 1992 Jan; 85(1):14-8. PubMed ID: 1734527
[TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
Melo-Cristino J; Fernandes ML; Serrano N;
Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
[TBL] [Abstract][Full Text] [Related]
13. The use of quinolones in respiratory tract infections.
Maesen FP; Davies BI; Geraedts WH; Baur C
Drugs; 1987; 34 Suppl 1():74-9. PubMed ID: 3325259
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of DL-8280 and amoxicillin in the treatment of respiratory tract infections].
Kobayashi H; Takamura K; Kono K; Onodera S; Sasaki N; Nagahama F; Kawakami Y; Honma Y; Matsuzaki M; Tanimura K
Kansenshogaku Zasshi; 1984 Jun; 58(6):525-55. PubMed ID: 6436407
[No Abstract] [Full Text] [Related]
15. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
[TBL] [Abstract][Full Text] [Related]
17. Infections of the lower respiratory tract: treatment with amoxicillin.
Burns MW; Devitt L
J Infect Dis; 1974 Jun; 129(0):suppl:S194-7. PubMed ID: 4152135
[No Abstract] [Full Text] [Related]
18. Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration.
Chow AW; Hall CB; Klein JO; Kammer RB; Meyer RD; Remington JS
Clin Infect Dis; 1992 Nov; 15 Suppl 1(Suppl 1):S62-88. PubMed ID: 1477253
[TBL] [Abstract][Full Text] [Related]
19. Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis.
Davies BI; Maesen FP; Baur C
Eur J Clin Microbiol; 1986 Apr; 5(2):226-31. PubMed ID: 2941287
[TBL] [Abstract][Full Text] [Related]
20. Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections.
Casellas JM; Gilardoni M; Tome G; Goldberg M; Ivanovic S; Orduna M; Dolmann A; Ascoli M; Ariza H; Montero JM
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():37-42. PubMed ID: 10404336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
